About 11 results.

1. CP19/2: Brexit and contractual continuity

   Consultation papers Published: 08/01/2019 Last modified: 17/01/2019
   The financial services contracts regime (FSCR) allows EEA firms to run off their regulated business in the UK, if the UK leaves the EU without an implementation period. This consultation paper sets out details of the FSCR and the rules we propose should apply to firms during the regime.

2. CP19/1: Recovering the costs of regulating securitisation repositories after the UK leaves the European Union

   Consultation papers Published: 08/01/2019 Last modified: 11/01/2019
   This paper sets out the fees structure we intend to establish for securitisation repositories (SRs) when responsibility for their regulation passes to us from ESMA (European Securities and Markets Authority) after the UK leaves the EU (European Union) on 29 March 2019. SRs are established under the Securitisation Regulation and none have yet been...

3. CP18/44: Brexit – Regulatory Technical Standards for Strong Customer Authentication and Common and Secure Open Standards of Communication

   Consultation papers Published: 19/12/2018 Last modified: 19/12/2018
   In this Consultation Paper we propose to make regulatory technical standards for strong customer authentication and common and secure open standards of communication, which will apply in the UK from 14 September 2019 in the event of a no-deal exit by the UK from the EU.

4. CP18/42: High-Cost Credit Review: Overdrafts consultation paper and policy statement

   Consultation papers Published: 18/12/2018 Last modified: 20/12/2018
   This paper sets out our proposals to radically reform the ways banks and building societies charge for overdrafts. It also sets out the rules we have made to address low awareness and engagement in this market.

5. CP18/43: High-Cost Credit Review: Feedback on CP18/12 with final rules and guidance and consultation on Buy Now Pay Later offers

   Consultation papers Published: 18/12/2018 Last modified: 18/12/2018
   As part of our review of high-cost credit products, we have published our feedback to CP18/12 and final rules and guidance in relation to home-collected credit, catalogue credit and store cards.

6. CP18/41: FCA and PRA changes to mortgage reporting requirements

   Consultation papers Published: 13/12/2018 Last modified: 13/12/2018
   In this consultation paper (CP), the FCA and the Prudential Regulation Authority (PRA) set out proposals for new reporting requirements that would apply to mortgage lenders and home finance administrators.

7. CP18/40: Consultation on proposed amendment of COBS 21.3 permitted links rules

   Consultation papers Published: 12/12/2018 Last modified: 12/12/2018
   In this paper, we are consulting on potential changes to our permitted links rules in our Conduct of Business (COBS) sourcebook. The purpose is to address any unjustified barriers these may present to investment by retail investors in a broader range of long-term assets in unit-linked funds, while continuing to offer an appropriate degree of...

8. CP18/39: Quarterly Consultation Paper No 23

   Consultation papers Published: 07/12/2018 Last modified: 07/12/2018
   Once a quarter, we consult on proposed miscellaneous amendments to our Handbook. These tend to be minor changes but we still want to get your feedback on our proposals.

9. CP18/37: Product intervention measures for retail binary options

   Consultation papers Published: 07/12/2018 Last modified: 07/12/2018
   In this paper, we propose permanent rules to prohibit the sale, marketing and distribution of binary options to retail consumers by firms that carry out activity in, or from, the UK.

10. CP18/38: Restricting contract for difference products sold to retail clients and a discussion of other retail derivative products

    Consultation papers Published: 07/12/2018 Last modified: 07/12/2018
    In this paper, we propose permanent rules to restrict how CFDs and CFD-like options are marketed, distributed, and sold to retail consumers. This paper also includes a discussion on whether other complex derivative products may pose similar risks of harm when sold to retail consumers and could benefit from similar measures.